GlassScriptPhysician profile
Bryant Adam Self
NPI 1437576352
$730.29
in general payments reported to CMS, 2019-2025
7 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.22 · 2020: $84.49 · 2023: $73.82 · 2024: $121 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.88 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $207.36 | 2020-2025 | Wegovy |
| Amgen INC. | $147.36 | 2025 | Repatha |
| Abbott Laboratories | $136.39 | 2025 | Triclip |
| E.R. Squibb & Sons, L.L.C. | $121.44 | 2024 | |
| Novartis Pharmaceuticals Corporation | $73.82 | 2023 | |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | |
| Sensible Medical Innovations INC | $18.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryant Self listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.